• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠组织中Ubc9蛋白的表达水平。

Expression level of Ubc9 protein in rat tissues.

作者信息

Gołebiowski Filip, Szulc Aneta, Sakowicz Monika, Szutowicz Andrzej, Pawełczyk Tadeusz

机构信息

Department of Molecular Medicine, Medical University of Gdańsk, 80-211 Gdańsk, Poland.

出版信息

Acta Biochim Pol. 2003;50(4):1065-73.

PMID:14739995
Abstract

Ubc9 is a homologue of the E2 ubiquitin conjugating enzyme and participates in the covalent linking of SUMO-1 molecule to the target protein. In this report we describe a simple and efficient method for obtaining pure human recombinant Ubc9 protein. The purified Ubc9 retained its native structure and was fully active in an in vitro sumoylation assay with the promyelocytic leukaemia (PML) peptide as a substrate. In order to better understand the physiology of Ubc9 protein we examined its levels in several rat tissues. Immunoblot analyses performed on tissue extracts revealed quantitative and qualitative differences in the expression pattern of Ubc9. The Ubc9 protein was present at a high level in spleen and lung. Moderate level of Ubc9 was detected in kidney and liver. Low amount of Ubc9 was observed in brain, whereas the 18 kDa band of Ubc9 was barely visible or absent in heart and skeletal muscle. In heart and muscle extracts the Ubc9 antibodies recognized a 38 kDa protein band. This band was not visible in extracts of other rat tissues. A comparison of the relative levels of Ubc9 mRNA and protein indicated that the overall expression level of Ubc9 was the highest in spleen and lung. In spleen, lung, kidney, brain, liver and heart there was a good correlation between the 18 kDa protein and Ubc9 mRNA levels. In skeletal muscle the Ubc9 mRNA level was unproportionally high comparing to the level of the 18 kDa protein. The presented data indicate that in the rat the expression of the Ubc9 protein appears to have some degree of tissue specificity.

摘要

Ubc9是E2泛素缀合酶的同源物,参与SUMO-1分子与靶蛋白的共价连接。在本报告中,我们描述了一种获得纯人重组Ubc9蛋白的简单有效方法。纯化后的Ubc9保留了其天然结构,并且在以早幼粒细胞白血病(PML)肽为底物的体外SUMO化分析中具有完全活性。为了更好地理解Ubc9蛋白的生理学特性,我们检测了它在几种大鼠组织中的水平。对组织提取物进行的免疫印迹分析揭示了Ubc9表达模式在数量和质量上的差异。Ubc9蛋白在脾脏和肺中高水平存在。在肾脏和肝脏中检测到中等水平的Ubc9。在脑中观察到Ubc9含量较低,而在心脏和骨骼肌中几乎看不到或不存在18 kDa的Ubc9条带。在心脏和肌肉提取物中,Ubc9抗体识别出一条38 kDa的蛋白条带。这条带在其他大鼠组织的提取物中不可见。Ubc9 mRNA和蛋白相对水平的比较表明,Ubc9的整体表达水平在脾脏和肺中最高。在脾脏、肺、肾脏、脑、肝脏和心脏中,18 kDa蛋白与Ubc9 mRNA水平之间存在良好的相关性。在骨骼肌中,Ubc9 mRNA水平与18 kDa蛋白水平相比异常高。所呈现的数据表明,在大鼠中,Ubc9蛋白的表达似乎具有一定程度的组织特异性。

相似文献

1
Expression level of Ubc9 protein in rat tissues.大鼠组织中Ubc9蛋白的表达水平。
Acta Biochim Pol. 2003;50(4):1065-73.
2
Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.小泛素样修饰物(SUMO)缀合酶Ubc9的位点特异性抑制选择性地损害SUMO链的形成。
J Biol Chem. 2017 Sep 15;292(37):15340-15351. doi: 10.1074/jbc.M117.794255. Epub 2017 Aug 7.
3
SUMO and SUMO-Conjugating Enzyme E2 UBC9 Are Involved in White Spot Syndrome Virus Infection in Fenneropenaeus chinensis.小泛素样修饰蛋白(SUMO)和SUMO缀合酶E2 UBC9参与中国明对虾的白斑综合征病毒感染。
PLoS One. 2016 Feb 29;11(2):e0150324. doi: 10.1371/journal.pone.0150324. eCollection 2016.
4
Developmental regulation of Ubc9 in the rat nervous system.大鼠神经系统中Ubc9的发育调控
Acta Biochim Pol. 2008;55(4):681-6. Epub 2008 Nov 28.
5
A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.ZNF 146的一个克鲁ppel锌指与SUMO-1缀合酶UBC9相互作用,并在体内发生SUMO化修饰。
Mol Cell Biochem. 2005 Mar;271(1-2):215-23. doi: 10.1007/s11010-005-6417-2.
6
Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.泛素样小分子修饰物SUMO的泛素结合酶Ubc9的纯化及活性测定。
Methods Enzymol. 2005;398:74-87. doi: 10.1016/S0076-6879(05)98008-7.
7
Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.相扑E2酶UBC9是心肌细胞中高效蛋白质质量控制所必需的。
Circ Res. 2014 Sep 26;115(8):721-9. doi: 10.1161/CIRCRESAHA.115.304760. Epub 2014 Aug 5.
8
Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.通过SUMO-Ubc9融合增强含有SUMO相互作用基序的蛋白质的SUMO化修饰。
Biochem Biophys Res Commun. 2009 Oct 9;388(1):41-5. doi: 10.1016/j.bbrc.2009.07.103. Epub 2009 Jul 25.
9
Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.泛素结合酶9(Ubc9)的类泛素化修饰调控酿酒酵母中的类泛素链形成及减数分裂联会。
Mol Cell. 2013 Jun 6;50(5):625-36. doi: 10.1016/j.molcel.2013.03.027. Epub 2013 May 2.
10
Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.鉴定参与转录调控的 PIAS1、SUMO1 和 UBC9 蛋白质形成的非共价三元复合物。
J Biol Chem. 2013 Dec 20;288(51):36312-27. doi: 10.1074/jbc.M113.486845. Epub 2013 Oct 30.

引用本文的文献

1
Exploring potential targets for natural product therapy of DN: the role of SUMOylation.探索糖尿病肾病天然产物疗法的潜在靶点:SUMO 化修饰的作用
Front Pharmacol. 2024 Oct 4;15:1432724. doi: 10.3389/fphar.2024.1432724. eCollection 2024.
2
Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents.通过抑制 CRMP2-Ubc9 相互作用选择性靶向 NaV1.7 可减少啮齿动物的疼痛。
Sci Transl Med. 2021 Nov 10;13(619):eabh1314. doi: 10.1126/scitranslmed.abh1314.
3
Variation in expression of small ubiquitin-like modifiers in injured sciatic nerve of mice.
小鼠坐骨神经损伤后小泛素样修饰物表达的变化
Neural Regen Res. 2019 Aug;14(8):1455-1461. doi: 10.4103/1673-5374.253531.
4
Deciphering the SUMO code in the kidney.解读肾脏中的 SUMO 密码。
J Cell Mol Med. 2019 Feb;23(2):711-719. doi: 10.1111/jcmm.14021. Epub 2018 Dec 1.
5
Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels.通过对 Ubc9-CRMP2 界面的化学位移扰动图谱分析,确定了 CRMP2 中的一个口袋,该口袋可作为变构调节剂来调节 Nav1.7 通道。
Channels (Austin). 2018;12(1):219-227. doi: 10.1080/19336950.2018.1491244. Epub 2018 Aug 6.
6
Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.抑制 Ubc9 E2 SUMO 连接酶-CRMP2 相互作用可减少 Nav1.7 电流并逆转实验性神经病理性疼痛。
Pain. 2018 Oct;159(10):2115-2127. doi: 10.1097/j.pain.0000000000001294.
7
Starting and stopping SUMOylation. What regulates the regulator?启动和终止类泛素化修饰。是什么调控了这种调控因子?
Chromosoma. 2013 Dec;122(6):451-63. doi: 10.1007/s00412-013-0422-0. Epub 2013 Jun 28.
8
Defective sumoylation pathway directs congenital heart disease.缺陷性的类泛素化途径导致先天性心脏病。
Birth Defects Res A Clin Mol Teratol. 2011 Jun;91(6):468-76. doi: 10.1002/bdra.20816. Epub 2011 May 11.
9
Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells.蛋白质SUMO化在冬眠蛰伏状态下大量增加,对于SHSY5Y细胞中缺血预处理和低温所提供的细胞保护作用至关重要。
J Cereb Blood Flow Metab. 2007 May;27(5):950-62. doi: 10.1038/sj.jcbfm.9600395. Epub 2006 Sep 6.
10
MyoD synergizes with the E-protein HEB beta to induce myogenic differentiation.肌分化决定因子(MyoD)与E蛋白HEBβ协同作用以诱导肌源性分化。
Mol Cell Biol. 2006 Aug;26(15):5771-83. doi: 10.1128/MCB.02404-05.